Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the use of inhaled beclomethasone after a
community-acquired respiratory viral infection in a lung transplant recipient decreases the
risk of the subsequent development of chronic lung allograft dysfunction.